$2.25
-0.11-4.66%
At close: -
$2.05
-0.20-8.89%
After Hours: 5:01 PM EDT
Comments
Loading...
Alto Neuroscience (ANRO) Forecast
NewsEarningsAlto Neuroscience (ANRO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Alto Neuroscience Stock Price, Quotes and Forecasts | NYSE:ANRO | Benzinga
Explore Alto Neuroscience stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ANRO.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Alto Neuroscience (ANRO) stock?
You can purchase shares of Alto Neuroscience (NYSE:ANRO) through any online brokerage.
Who are Alto Neuroscience (ANRO) competitors?
Other companies in Alto Neuroscience’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Universe Pharmaceuticals (NASDAQ:UPC), Neumora Therapeutics (NASDAQ:NMRA) and Rani Therapeutics Hldgs (NASDAQ:RANI).
What is the forecast, or price target, for Alto Neuroscience (ANRO) stock?
Alto Neuroscience has a consensus price target of $18.29.
What is the current price for Alto Neuroscience (ANRO)?
The stock price for Alto Neuroscience (NYSE: ANRO) is $2.05 last updated April 16, 2025 at 5:01 PM EDT.
Does Alto Neuroscience (ANRO) pay a dividend?
There are no upcoming dividends for Alto Neuroscience.
When is Alto Neuroscience (NYSE:ANRO) reporting earnings?
Alto Neuroscience’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
Is Alto Neuroscience (ANRO) going to split?
There is no upcoming split for Alto Neuroscience.
What sector and industry does Alto Neuroscience (ANRO) operate in?
Alto Neuroscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.